KP Tissue Inc.
KPTSF
$7.80
$0.030.39%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- |
| Operating Income | -- | -- | -- | -- | -- |
| Income Before Tax | 237.71% | -26.49% | 113.32% | 45.11% | -185.76% |
| Income Tax Expenses | -- | -- | -- | -- | -74.68% |
| Earnings from Continuing Operations | 233.81% | -26.49% | 113.32% | 45.11% | -197.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 233.81% | -26.49% | 113.32% | 45.11% | -197.93% |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 233.43% | -26.66% | 112.83% | 44.66% | -197.72% |
| Normalized Basic EPS | 223.88% | -28.46% | 130.04% | 76.24% | -202.47% |
| EPS Diluted | 233.43% | -26.66% | 112.83% | 44.66% | -197.72% |
| Normalized Diluted EPS | 223.88% | -28.46% | 130.04% | 76.24% | -202.47% |
| Average Basic Shares Outstanding | 0.28% | 0.28% | 0.27% | 0.26% | 0.24% |
| Average Diluted Shares Outstanding | 0.28% | 0.28% | 0.27% | 0.26% | 0.24% |
| Dividend Per Share | 0.39% | -0.98% | -1.06% | -6.07% | -2.80% |
| Payout Ratio | 1.75% | 0.34% | -0.54% | -0.36% | -1.99% |